Hey Malka,
I love the analysis that you have done.
A projected SP of $6.40 at 2025 just for OSA is music to my ears.
Great results for all IHL shareholders today.
Massive actually to think that
80% of trial participants experienced a reduction in AHI levels of greater than 55% to 91.5% during at least one treatment compared to baseline
I think all posters can breathe a sigh of relief now that their positive pre-release analysis has been validated.
Congrats to all BOD members and staff.
I am looking forward to some SP appreciation over the coming days and weeks as the PR machine kicks in.
We can now do some real and legitimate comparisons and analyses with RESMED's market share as per @malkazoid 's post.
Looking forward to the next moves by the BOD
GLAH
- Forums
- ASX - By Stock
- IHL
- Ann: IHL-42X positive phase 2 clinical trial results
Ann: IHL-42X positive phase 2 clinical trial results, page-80
-
- There are more pages in this discussion • 310 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IHL (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
JBY
JAMES BAY MINERALS LIMITED
Andrew Dornan, Executive Director
Andrew Dornan
Executive Director
SPONSORED BY The Market Online